MDMA-Assisted Psychotherapy

Cross-source consensus on MDMA-Assisted Psychotherapy from 1 sources and 6 claims.

1 sources · 6 claims

How it works

Australia approved prescription of MDMA by authorised psychiatrists for PTSD in 2023. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study
MDMA-assisted psychotherapy has shown promising results in clinical trials for post-traumatic stress disorder. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study
Limited clinical use of MDMA-assisted psychotherapy is approved in Canada and Switzerland. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study
The first United States New Drug Application for MDMA-assisted psychotherapy for PTSD was unsuccessful because of limitations in the existing data. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study
Challenging material in MDMA-assisted psychotherapy may cause unintended harms if not handled by appropriately skilled clinicians. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study
MDMA-assisted psychotherapy may increase difficult emotions and memories so they can be processed with clinician support. — Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study